The Livingston Group on Behalf of Innovative Vaccine Technologies
Government and public relations consultants
Based in DC
🤖
AI Overview
With $430K in lobbying spend across 20 quarterly filings, The Livingston Group on Behalf of Innovative Vaccine Technologies is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2025.
$430K
Total Spend
5
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $90K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $80K |
| 2025 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Budget/Appropriations
- •FY'22 Appropriations for clinical trials for new vaccine platform
- •FY'22 defense appropriations bill for the development of a synthetic vaccine
- •FY'22 defense appropriation bill for the development of a synthetic vaccine
Related Analysis
Related Investigations
Similar Clients
American Clinical Laboratory Assn
$23.9M total spend
Catholic Health Association of the United States
$6.2M total spend
Ickes & Enright Group (Northwell Health FKA North Shore-lij)
$3.4M total spend
Alliance for Biosecurity
$2.8M total spend
Association for Diagnostics & Laboratory Medicine (Formerly Aacc)
$2.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.